Article

Personalization of Radiotherapy Dose in HPV Positive Oropharynx Cancer Using GARD

2023-09-14

Abstract excerpt

<h4>ABSTRACT</h4> A central clinical goal for patients with HPV-positive oropharynx cancer has been to reduce radiation doses while maintaining cure rates. Recent results of Phase 3 prospective trial HN005 demonstrated that RT dose de-escalation can not be safely done based on clinical factors alone. We have previously shown that the genomic adjusted radiation dose (GARD) is predictive of radiation treatment benef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 736d3c0d-9dee-5165-acae-b606e0b82fc1
DOI: 10.1101/2023.09.14.23295538

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Personalization of Radiotherapy Dose in HPV Positive Oropharynx Cancer Using GARDDOI 10.1101/2023.09.14.23295538Read

GARD is a pan-cancer predictor of radiation therapy benefitSemantic proximity Read

Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with RadiotherapySemantic proximity Read

Genomic-adjusted radiation dose and outcomes in radiotherapy-treated locally advanced rectal cancer: a pooled multicohort analysis including the TIMING, OPRA, and CAO/ARO/AIO-94 prospective trialsSemantic proximity Read

Genomic-Adjusted Radiation Dose from Bulk RNA Sequencing for Personalized RadiotherapySemantic proximity Read

Genomically Adjusted Radiation Dose Predicts Outcomes in Pediatric Brain Tumors and Supports Biologically Personalized RadiotherapySemantic proximity Read

Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of RadiosensitivitySemantic proximity Read

Tobacco exposure as a major modifier of oncologic outcomes in Human PapillomaVirus (HPV) associated oropharyngeal squamous cell carcinomaSemantic proximity Read

<i>In Vivo</i> Assessment of the Safety of Standard Fractionation Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma: An R-IDEAL Stage 1/2a First-in-Humans/Feasibility Demonstration of New Technology ImplementationSemantic proximity Read

The future of personalised radiotherapy for head and neck cancer.Semantic proximity Read

Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.Semantic proximity Read

Patterns of Radiotherapy Practice, Dosimetric Exposure, and Treatment Outcomes in Esophageal Cancer:A Retrospective Cohort Study from a Tertiary Care CenterSemantic proximity Read

Design and validation of an automated radiation therapy treatment planning approach for locally advanced lung cancerSemantic proximity Read